SYG Biotech

Startup

SYG BIOTECH is an innovative biotechnology company dedicated to the research and development of revolutionary healthcare solutions. Since our founding in 2021, we have developed advanced technologies for the rapid in vitro selection of new therapeutic proteins, including VHHS, DARPINS, and other peptides. Our innovations specifically target immune checkpoints, such as PD-1/PD-L1, offering promising prospects for the treatment of various diseases, particularly in oncology. Our latest development, a rapid detection kit for PD-1 and PD-L1, enables researchers to detect and analyze these biomarkers with unprecedented accuracy, thus facilitating the development of personalized therapies.